Filana Therapeutics, Inc. Retained Earnings
Filana Therapeutics, Inc. (FLNA) had Retained Earnings of -$506.42 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-07
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$506.42M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$496.08M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$483.55M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$472.74M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-03-31 | -$506.42M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$496.08M 10-Q · filed 2026-05-07 |
| 2025-09-30 | -$483.55M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$472.74M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$428.51M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$405.11M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$377.51M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$349.57M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$355.73M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$380.77M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$359.85M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$334.20M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$307.82M 10-Q · filed 2023-05-01 |
| 2022-12-31 | -$283.55M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$264.42M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$244.16M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$224.83M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$207.31M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$193.13M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$183.57M 10-Q · filed 2021-08-04 |
| 2021-03-31 | -$178.45M 10-Q · filed 2021-04-29 |
| 2020-12-31 | -$174.92M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$172.30M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$170.87M 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$169.74M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$168.59M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$167.07M 10-Q · filed 2019-10-29 |
| 2019-06-30 | -$166.37M 10-Q · filed 2019-08-12 |
| 2019-03-31 | -$165.31M 10-Q · filed 2019-05-02 |
| 2018-12-31 | -$163.96M 10-K · filed 2020-03-26 |
| 2018-09-30 | -$163.28M 10-Q · filed 2018-10-30 |
| 2018-06-30 | -$162.01M 10-Q · filed 2018-07-26 |
| 2018-03-31 | -$159.56M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$157.40M 10-K · filed 2019-03-29 |
| 2017-09-30 | -$154.98M 10-Q · filed 2017-11-01 |
| 2017-06-30 | -$152.39M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$148.23M 10-Q · filed 2017-04-26 |
| 2016-12-31 | -$145.49M 10-K · filed 2018-02-06 |
| 2016-09-30 | -$142.97M 10-Q · filed 2016-10-26 |
| 2016-06-30 | -$139.45M 10-Q · filed 2016-07-19 |
| 2016-03-31 | -$136.43M 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$130.64M 10-K · filed 2017-03-07 |
| 2015-09-30 | -$126.12M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$122.45M 10-Q · filed 2015-07-23 |
| 2015-03-31 | -$119.08M 10-Q · filed 2015-05-08 |
| 2014-12-31 | -$116.49M 10-K · filed 2016-03-03 |
| 2014-09-30 | -$114.34M 10-Q · filed 2014-11-05 |
| 2014-06-30 | -$110.80M 10-Q · filed 2014-08-06 |
| 2014-03-31 | -$107.56M 10-Q · filed 2014-05-07 |
| 2013-12-31 | -$104.11M 10-K · filed 2015-02-18 |
| 2013-09-30 | -$137.12M 10-Q · filed 2013-11-01 |
| 2013-06-30 | -$136.36M 10-Q · filed 2013-08-01 |
| 2013-03-31 | -$136.06M 10-Q · filed 2013-04-24 |
| 2012-12-31 | -$135.65M 10-K · filed 2014-02-05 |
| 2012-09-30 | -$133.86M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$132.31M 10-Q · filed 2012-08-02 |
| 2012-03-31 | -$132.18M 10-Q · filed 2012-05-08 |
| 2011-12-31 | -$132.21M 10-K · filed 2013-02-08 |
| 2011-09-30 | -$131.81M 10-Q · filed 2011-11-03 |
| 2011-06-30 | -$131.00M 10-Q · filed 2011-08-04 |
| 2010-12-31 | -$129.59M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |